{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"description":"Efficacy of the pre-incubation of one of two umbilical cord blood (UCB) units with C3a as part of a unrelated donor double UCB nonmyeloablative transplantation in patients with high-risk hematological malignancies.","groups":[{"description":"Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.","id":"OG000","title":"Complement Fragment 3A - Small Cell Dose"},{"description":"Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.","id":"OG001","title":"Complement Fragment A - Larger Cell Dose"}],"paramType":"NUMBER","populationDescription":"Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.","reportingStatus":"POSTED","timeFrame":"Day 180","title":"Number of Patients With the Complement 3a (C3a) Unit Predominating","type":"PRIMARY","unitOfMeasure":"participants"}